fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
fincash number+91-22-62820123
Best Performing Equity Mutual Funds 2021 | Fincash.com

Fincash » Mutual Funds » Best Equity Funds

Best Equity Mutual Funds 2021 - 2022

Updated on January 17, 2021 , 22209 views

An equity fund is a mutual fund that invests principally in stocks. It can be actively or passively (index fund) managed. These are also known as stock funds.

Best Equity Funds

Equity Funds should be the vehicle of choice when Investing for long-term goals as they have created huge profits for investors in the past few years. But as there is a wide choice before investors, choosing the right equity fund becomes critical.

With right qualitative and quantitative measures (discussed below), one can ideally choose the best equity Mutual Funds to invest.

Why to Invest in Equity Funds?

1. Liquidity

Since stocks are actively traded across all major exchanges, every day, this makes equity funds a highly liquid investment. It provides investors, the convenience of buying and selling their stocks depending on the market situation. By investing in equity mutual funds, the money is usually credited to your Bank account in 3 days.

2. Dividend Income

Investing into blue-chip companies may help investors earn a steady Income in the form of dividends. A majority of such companies usually pay out regular dividends even in volatile market conditions, typically paid quarterly. Having a diversified portfolio can provide investors with a steady dividend income in the year.

3. Portfolio Diversification

With best equity mutual funds investors can diversify their portfolio through regularly investing. It means that they can invest in stocks of different economic sectors. So, even if a particular stock drops in value, the others may help investors make up for that loss depending on the market situation.

4. Ideal Investment Vehicle

In many ways, equity funds are ideal investment vehicles for investors that are not as well-versed in financial investing or do not possess a large amount of Capital with which to invest. They are practical investments for most people.

The attributes that make equity funds most suitable for small individual investors are the reduction of risk resulting from a fund's portfolio diversification and the relatively small amount of capital required to acquire shares of an equity fund. A large amount of investment capital would be required for an individual investor to achieve a similar degree of risk reduction through diversification of a portfolio of direct stock holdings. Pooling small investors capital allows an equity fund to diversify effectively without burdening each investor with large capital requirements.

Equity NAV

The price of the equity fund is based on the fund's net asset value (NAV) less its liabilities. A more diversified fund means that there is less negative effect of an individual stock's adverse price movement on the overall portfolio and on the share price of the equity fund.

Equity funds are managed by experienced professional portfolio managers, and their past performance is a matter of public record. Transparency and reporting requirements for equity funds are heavily regulated by the Security Exchange Board of India (SEBI)

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Top Equity Mutual Funds 2021

Best equity mutual funds are categorised according to its types- ELSS, Large cap funds, mid cap funds, Small cap funds, Diversified Funds, sector funds and Balanced Fund.

5 Best Large Cap Equity Mutual Funds

FundNAVNet Assets (Cr)3 MO (%)6 MO (%)1 YR (%)3 YR (%)5 YR (%)2020 (%)
Axis Bluechip Fund Growth ₹38.88
↑ 0.66
₹22,51721.330.3191516.919.7
Canara Robeco Bluechip Equity Fund Growth ₹34.45
↑ 0.51
₹1,36421.130.723.714.216.623.1
BNP Paribas Large Cap Fund Growth ₹117.58
↑ 1.67
₹1,0512128.517.79.913.716.8
Kotak Bluechip Fund Growth ₹305.448
↑ 4.30
₹2,06720.931.718.59.714.116.4
SBI Bluechip Fund Growth ₹50.3164
↑ 0.84
₹25,9252635.719.18.413.516.3
Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 19 Jan 21

5 Best Mid Cap Equity Mutual Funds

FundNAVNet Assets (Cr)3 MO (%)6 MO (%)1 YR (%)3 YR (%)5 YR (%)2020 (%)
Axis Mid Cap Fund Growth ₹50.97
↑ 0.85
₹8,51520.732.224.613.317.326
PGIM India Midcap Opportunities Fund Growth ₹28.63
↑ 0.57
₹604264847.611.315.148.4
Invesco India Mid Cap Fund Growth ₹65.2
↑ 1.13
₹1,22822.635.223.68.115.324.4
DSP BlackRock Midcap Fund Growth ₹73.542
↑ 1.15
₹9,82319.832.1227.716.723.6
Kotak Emerging Equity Scheme Growth ₹51.611
↑ 0.88
₹9,01625.240.620.8716.521.9
Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 19 Jan 21

5 Best Small Cap Equity Mutual Funds

FundNAVNet Assets (Cr)3 MO (%)6 MO (%)1 YR (%)3 YR (%)5 YR (%)2020 (%)
Kotak Small Cap Fund Growth ₹102.655
↑ 1.35
₹2,37227.855.631.56.816.134.2
SBI Small Cap Fund Growth ₹73.6772
↑ 1.07
₹6,62826.147.130.95.118.933.6
Nippon India Small Cap Fund Growth ₹51.6505
↑ 0.72
₹10,91625.24523.82.215.929.2
ICICI Prudential Smallcap Fund Growth ₹32.7
↑ 0.42
₹1,7782648.619.72.212.222.8
DSP BlackRock Small Cap Fund  Growth ₹72.804
↑ 1.00
₹6,0012243.725.10.51333.1
Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 19 Jan 21

5 Best Large & Mid Cap Equity Mutual Funds

FundNAVNet Assets (Cr)3 MO (%)6 MO (%)1 YR (%)3 YR (%)5 YR (%)2020 (%)
Mirae Asset Emerging Bluechip Fund Growth ₹74.382
↑ 1.22
₹14,30224.637.124.611.620.622.4
Invesco India Growth Opportunities Fund Growth ₹42.88
↑ 0.71
₹3,47219.630.914.98.71513.3
Kotak Equity Opportunities Fund Growth ₹154.712
↑ 2.14
₹4,63320.129.716.38.715.716.5
Edelweiss Large and Mid Cap Fund  Growth ₹40.322
↑ 0.64
₹6152233.618.78.614.317
Canara Robeco Emerging Equities Growth ₹124.3
↑ 1.84
₹7,31322.235.123.68.317.424.5
Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 19 Jan 21

5 Best Equity Linked Savings Schemes (ELSS)

FundNAVNet Assets (Cr)3 MO (%)6 MO (%)1 YR (%)3 YR (%)5 YR (%)2020 (%)
Canara Robeco Equity Tax Saver Growth ₹90.51
↑ 1.43
₹1,4762135.829.314.116.727.4
Mirae Asset Tax Saver Fund Growth ₹24.277
↑ 0.39
₹5,48923.437.623.911.720.821.5
Axis Long Term Equity Fund Growth ₹59.7834
↑ 1.09
₹27,18125.535.118.711.415.920.5
Invesco India Tax Plan Growth ₹65.84
↑ 1.06
₹1,38620.830.919.69.114.919.2
Kotak Tax Saver Fund Growth ₹55.7
↑ 0.76
₹1,52719.730.614.78.71514.9
Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 19 Jan 21

5 Best Diversified/Multi Cap Equity Mutual Funds

FundNAVNet Assets (Cr)3 MO (%)6 MO (%)1 YR (%)3 YR (%)5 YR (%)2020 (%)
UTI Equity Fund Growth ₹204.835
↑ 3.49
₹14,86126.742.330.81517.231.5
Parag Parikh Long Term Equity Fund Growth ₹35.7861
↑ 0.22
₹6,39312.325.630.314.117.532.3
PGIM India Diversified Equity Fund Growth ₹19.61
↑ 0.25
₹50323.337.53512.215.935.9
Canara Robeco Equity Diversified Growth ₹178.23
↑ 2.65
₹3,05619.230.522.21215.922.2
DSP BlackRock Equity Fund Growth ₹52.517
↑ 0.82
₹4,61325.833.618.99.61618.7
Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 19 Jan 21

5 Best Sector Equity Mutual Funds

FundNAVNet Assets (Cr)3 MO (%)6 MO (%)1 YR (%)3 YR (%)5 YR (%)2020 (%)
ICICI Prudential Technology Fund Growth ₹102.16
↑ 0.53
₹1,18521.461.568.626.920.670.6
Nippon India Pharma Fund Growth ₹256.45
↑ 4.28
₹4,38312.929.663.72113.266.4
SBI Healthcare Opportunities Fund Growth ₹200.814
↑ 3.21
₹1,57512.631.562.615865.8
UTI Healthcare Fund Growth ₹142.904
↑ 1.96
₹64910.629.761.116.31067.4
TATA India Pharma & Healthcare Fund Growth ₹15.1985
↑ 0.26
₹41912.130.558.6199.464.4
Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 19 Jan 21

5 Best Focused Equity Funds

FundNAVNet Assets (Cr)3 MO (%)6 MO (%)1 YR (%)3 YR (%)5 YR (%)2020 (%)
IIFL Focused Equity Fund Growth ₹23.3726
↑ 0.37
₹1,35324.136.425.814.718.623.8
Axis Focused 25 Fund Growth ₹37.59
↑ 0.69
₹14,35824.534.519.111.218.321
Principal Focused Multicap Fund Growth ₹85.35
↑ 1.58
₹48323.430.421.410.415.119.7
Motilal Oswal Focused 25 Fund  Growth ₹29.3591
↑ 0.46
₹1,54820.931.719.79.914.517.3
Sundaram Select Focus Fund Growth ₹225.041
↑ 3.65
₹1,18521.328.614.39.714.411.9
Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 19 Jan 21

5 Best Dividend Yield Equity Funds

FundNAVNet Assets (Cr)3 MO (%)6 MO (%)1 YR (%)3 YR (%)5 YR (%)2020 (%)
UTI Dividend Yield Fund Growth ₹81.6472
↑ 1.04
₹2,53120.627.821.1813.918.9
Principal Dividend Yield Fund Growth ₹67.94
↑ 1.02
₹18721.629.8217.216.420.2
Templeton India Equity Income Fund Growth ₹59.4727
↑ 0.74
₹93926.841246.114.422.9
Aditya Birla Sun Life Dividend Yield Fund Growth ₹192.33
↑ 1.97
₹7421825.413.10.99.116.1
ICICI Prudential Dividend Yield Equity Fund Growth ₹18.8
↑ 0.28
₹20726.929.914.4011.514.1
Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 19 Jan 21

5 Best Value Equity Funds

FundNAVNet Assets (Cr)3 MO (%)6 MO (%)1 YR (%)3 YR (%)5 YR (%)2020 (%)
UTI Value Opportunities Fund Growth ₹80.5073
↑ 1.28
₹5,20225.335.421.29.713.919
ICICI Prudential Value Discovery Fund Growth ₹185.66
↑ 2.57
₹17,44325.531.326.77.312.222.9
JM Value Fund Growth ₹39.9111
↑ 0.80
₹12828.334.214.65.515.713.4
Nippon India Value Fund Growth ₹91.5196
↑ 1.51
₹3,32224.936.918.85.213.316.3
Tata Equity PE Fund Growth ₹161.208
↑ 2.02
₹4,62016.927.414.24.115.212.5
Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 19 Jan 21

*Below is list of Equity Funds having AUM >= 50 Crore having best returns in last 1 Year.

1. ICICI Prudential Technology Fund

To generate long-term capital appreciation for you from a portfolio made up predominantly of equity and equity-related securities of technology intensive companies.

ICICI Prudential Technology Fund is a Equity - Sectoral fund was launched on 3 Mar 00. It is a fund with High risk and has given a CAGR/Annualized return of 11.8% since its launch.  Ranked 37 in Sectoral category.  Return for 2020 was 70.6% , 2019 was 2.3% and 2018 was 19.1% .

Below is the key information for ICICI Prudential Technology Fund

ICICI Prudential Technology Fund
Growth
Launch Date 3 Mar 00
NAV (19 Jan 21) ₹102.16 ↑ 0.53   (0.52 %)
Net Assets (Cr) ₹1,185 on 31 Dec 20
Category Equity - Sectoral
AMC ICICI Prudential Asset Management Company Limited
Rating
Risk High
Expense Ratio 2.6
Sharpe Ratio 1.59
Information Ratio -0.49
Alpha Ratio 6.17
Min Investment 5,000
Min SIP Investment 100
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

DateValue
31 Dec 15₹10,000
31 Dec 16₹9,603
31 Dec 17₹11,505
31 Dec 18₹13,704
31 Dec 19₹14,026
31 Dec 20₹23,927

ICICI Prudential Technology Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹505,644.
Net Profit of ₹205,644
Invest Now

Returns for ICICI Prudential Technology Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 19 Jan 21

DurationReturns
1 Month 8.7%
3 Month 21.4%
6 Month 61.5%
1 Year 68.6%
3 Year 26.9%
5 Year 20.6%
10 Year
15 Year
Since launch 11.8%
Historical performance (Yearly) on absolute basis
YearReturns
2020 70.6%
2019 2.3%
2018 19.1%
2017 19.8%
2016 -4%
2015 3.9%
2014 26.3%
2013 62.6%
2012 17.1%
2011 -18.9%
Fund Manager information for ICICI Prudential Technology Fund
NameSinceTenure
Sankaran Naren14 Jul 173.47 Yr.
Priyanka Khandelwal8 Jul 200.48 Yr.
Vaibhav Dusad2 May 200.67 Yr.

Data below for ICICI Prudential Technology Fund as on 31 Dec 20

Equity Sector Allocation
SectorValue
Technology67.26%
Communication Services16.32%
Industrials9.44%
Consumer Cyclical1.26%
Financial Services0.83%
Consumer Defensive0.74%
Health Care0.53%
Asset Allocation
Asset ClassValue
Cash3.62%
Equity96.38%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Infosys Ltd (Technology)
Equity, Since 30 Apr 08 | INFY
21%₹247 Cr1,966,037
↑ 40,000
HCL Technologies Ltd (Technology)
Equity, Since 30 Sep 20 | HCLTECH
8%₹98 Cr1,039,744
↑ 260,000
Tech Mahindra Ltd (Technology)
Equity, Since 31 Oct 16 | 532755
6%₹73 Cr749,505
↑ 126,374
Persistent Systems Ltd (Technology)
Equity, Since 31 May 20 | PERSISTENT
4%₹48 Cr317,847
↑ 79,802
Bharti Airtel Ltd (Communication Services)
Equity, Since 31 May 20 | BHARTIARTL
4%₹48 Cr936,840
↓ -50,000
IndiaMART InterMESH Ltd (Communication Services)
Equity, Since 30 Jun 20 | 542726
4%₹43 Cr66,804
↑ 4,000
Tata Consultancy Services Ltd (Technology)
Equity, Since 30 Sep 19 | TCS
3%₹34 Cr120,185
Cyient Ltd (Industrials)
Equity, Since 30 Jun 18 | CYIENT
3%₹34 Cr657,374
↑ 52,966
Coforge Ltd (Technology)
Equity, Since 31 Jul 20 | 532541
3%₹32 Cr118,903
↓ -10,000
Firstsource Solutions Ltd (Technology)
Equity, Since 31 Aug 20 | 532809
3%₹31 Cr3,049,435
↓ -100,000

2. Nippon India Pharma Fund

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

Nippon India Pharma Fund is a Equity - Sectoral fund was launched on 5 Jun 04. It is a fund with High risk and has given a CAGR/Annualized return of 21.6% since its launch.  Ranked 35 in Sectoral category.  Return for 2020 was 66.4% , 2019 was 1.7% and 2018 was 3.6% .

Below is the key information for Nippon India Pharma Fund

Nippon India Pharma Fund
Growth
Launch Date 5 Jun 04
NAV (19 Jan 21) ₹256.45 ↑ 4.28   (1.70 %)
Net Assets (Cr) ₹4,383 on 31 Dec 20
Category Equity - Sectoral
AMC Nippon Life Asset Management Ltd.
Rating
Risk High
Expense Ratio 2.13
Sharpe Ratio 1.79
Information Ratio 1.16
Alpha Ratio 6.62
Min Investment 5,000
Min SIP Investment 100
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

DateValue
31 Dec 15₹10,000
31 Dec 16₹8,942
31 Dec 17₹9,623
31 Dec 18₹9,973
31 Dec 19₹10,141
31 Dec 20₹16,878

Nippon India Pharma Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹426,080.
Net Profit of ₹126,080
Invest Now

Returns for Nippon India Pharma Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 19 Jan 21

DurationReturns
1 Month 2.7%
3 Month 12.9%
6 Month 29.6%
1 Year 63.7%
3 Year 21%
5 Year 13.2%
10 Year
15 Year
Since launch 21.6%
Historical performance (Yearly) on absolute basis
YearReturns
2020 66.4%
2019 1.7%
2018 3.6%
2017 7.6%
2016 -10.6%
2015 19.4%
2014 49.5%
2013 20.9%
2012 34.8%
2011 -11%
Fund Manager information for Nippon India Pharma Fund
NameSinceTenure
Sailesh Raj Bhan1 Apr 0515.76 Yr.

Data below for Nippon India Pharma Fund as on 31 Dec 20

Equity Sector Allocation
SectorValue
Health Care97.72%
Asset Allocation
Asset ClassValue
Cash2.28%
Equity97.72%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 09 | SUNPHARMA
11%₹474 Cr8,000,976
Aurobindo Pharma Ltd (Healthcare)
Equity, Since 31 Dec 15 | AUROPHARMA
11%₹461 Cr5,000,000
Cipla Ltd (Healthcare)
Equity, Since 31 May 08 | 500087
9%₹410 Cr5,000,000
Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB
9%₹403 Cr1,050,000
↓ -50,000
Lupin Ltd (Healthcare)
Equity, Since 31 Aug 08 | 500257
9%₹391 Cr4,000,025
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 30 Jun 11 | 500124
9%₹390 Cr750,000
↑ 125,000
Cadila Healthcare Ltd (Healthcare)
Equity, Since 31 Jan 18 | 532321
7%₹286 Cr5,998,982
Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Aug 18 | 532843
6%₹248 Cr16,003,541
↑ 1,600,000
Gland Pharma Ltd (Healthcare)
Equity, Since 30 Nov 20 | GLAND
4%₹191 Cr814,523
↓ -458,241
Thyrocare Technologies Ltd (Healthcare)
Equity, Since 31 May 16 | THYROCARE
4%₹186 Cr2,041,561
↓ -61,549

3. SBI Healthcare Opportunities Fund

(Erstwhile SBI Pharma Fund)

To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy.

SBI Healthcare Opportunities Fund is a Equity - Sectoral fund was launched on 31 Dec 04. It is a fund with High risk and has given a CAGR/Annualized return of 14.7% since its launch.  Ranked 34 in Sectoral category.  Return for 2020 was 65.8% , 2019 was -0.5% and 2018 was -9.9% .

Below is the key information for SBI Healthcare Opportunities Fund

SBI Healthcare Opportunities Fund
Growth
Launch Date 31 Dec 04
NAV (19 Jan 21) ₹200.814 ↑ 3.21   (1.63 %)
Net Assets (Cr) ₹1,575 on 31 Dec 20
Category Equity - Sectoral
AMC SBI Funds Management Private Limited
Rating
Risk High
Expense Ratio 2.37
Sharpe Ratio 1.87
Information Ratio -0.04
Alpha Ratio 8.2
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-15 Days (0.5%),15 Days and above(NIL)

Growth of 10,000 investment over the years.

DateValue
31 Dec 15₹10,000
31 Dec 16₹8,598
31 Dec 17₹8,775
31 Dec 18₹7,907
31 Dec 19₹7,868
31 Dec 20₹13,048

SBI Healthcare Opportunities Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹376,357.
Net Profit of ₹76,357
Invest Now

Returns for SBI Healthcare Opportunities Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 19 Jan 21

DurationReturns
1 Month 3.3%
3 Month 12.6%
6 Month 31.5%
1 Year 62.6%
3 Year 15%
5 Year 8%
10 Year
15 Year
Since launch 14.7%
Historical performance (Yearly) on absolute basis
YearReturns
2020 65.8%
2019 -0.5%
2018 -9.9%
2017 2.1%
2016 -14%
2015 27.1%
2014 56.8%
2013 26%
2012 37.1%
2011 -5.5%
Fund Manager information for SBI Healthcare Opportunities Fund
NameSinceTenure
Tanmaya Desai1 Jun 119.59 Yr.

Data below for SBI Healthcare Opportunities Fund as on 31 Dec 20

Equity Sector Allocation
SectorValue
Health Care98.56%
Asset Allocation
Asset ClassValue
Cash1.1%
Equity98.9%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA
10%₹160 Cr2,700,000
↑ 700,000
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 20 | 500124
10%₹156 Cr300,000
Lupin Ltd (Healthcare)
Equity, Since 31 Jul 18 | 500257
9%₹147 Cr1,500,000
Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | 500087
9%₹141 Cr1,720,000
↓ -80,000
Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB
9%₹138 Cr360,000
↓ -20,000
Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Apr 20 | AUROPHARMA
9%₹138 Cr1,500,000
↓ -180,000
Narayana Hrudayalaya Ltd (Healthcare)
Equity, Since 31 Dec 19 | NH
5%₹72 Cr1,600,000
Strides Pharma Science Ltd (Healthcare)
Equity, Since 31 Mar 14 | STAR
4%₹66 Cr750,000
↓ -50,000
Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 Jul 20 | ALKEM
4%₹59 Cr200,000
↑ 20,000
Abbott India Ltd (Healthcare)
Equity, Since 31 Mar 19 | 500488
4%₹55 Cr35,000
↑ 10,000

4. UTI Healthcare Fund

(Erstwhile UTI Pharma & Healthcare Fund)

The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors.

UTI Healthcare Fund is a Equity - Sectoral fund was launched on 28 Jun 99. It is a fund with High risk and has given a CAGR/Annualized return of 14.6% since its launch.  Ranked 40 in Sectoral category.  Return for 2020 was 67.4% , 2019 was 1.2% and 2018 was -7.5% .

Below is the key information for UTI Healthcare Fund

UTI Healthcare Fund
Growth
Launch Date 28 Jun 99
NAV (19 Jan 21) ₹142.904 ↑ 1.96   (1.39 %)
Net Assets (Cr) ₹649 on 31 Dec 20
Category Equity - Sectoral
AMC UTI Asset Management Company Ltd
Rating
Risk High
Expense Ratio 2.59
Sharpe Ratio 1.81
Information Ratio 0.36
Alpha Ratio 6.74
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

DateValue
31 Dec 15₹10,000
31 Dec 16₹9,029
31 Dec 17₹9,589
31 Dec 18₹8,867
31 Dec 19₹8,971
31 Dec 20₹15,014

UTI Healthcare Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹385,859.
Net Profit of ₹85,859
Invest Now

Returns for UTI Healthcare Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 19 Jan 21

DurationReturns
1 Month 1.4%
3 Month 10.6%
6 Month 29.7%
1 Year 61.1%
3 Year 16.3%
5 Year 10%
10 Year
15 Year
Since launch 14.6%
Historical performance (Yearly) on absolute basis
YearReturns
2020 67.4%
2019 1.2%
2018 -7.5%
2017 6.2%
2016 -9.7%
2015 12.4%
2014 43.7%
2013 23.3%
2012 24.8%
2011 -9.6%
Fund Manager information for UTI Healthcare Fund
NameSinceTenure
V Srivatsa3 Mar 173.83 Yr.

Data below for UTI Healthcare Fund as on 31 Dec 20

Equity Sector Allocation
SectorValue
Health Care94.5%
Basic Materials2.22%
Asset Allocation
Asset ClassValue
Cash3.27%
Equity96.73%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA
10%₹67 Cr1,132,558
↓ -106,562
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | 500124
9%₹58 Cr110,782
↓ -3,408
Aurobindo Pharma Ltd (Healthcare)
Equity, Since 31 Oct 13 | AUROPHARMA
9%₹58 Cr624,369
↑ 55,822
Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 500087
8%₹54 Cr654,227
↑ 15,676
Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB
7%₹43 Cr111,549
↓ -13,534
Eris Lifesciences Ltd Registered Shs (Healthcare)
Equity, Since 31 Mar 19 | 540596
5%₹34 Cr578,554
↑ 88,828
Cadila Healthcare Ltd (Healthcare)
Equity, Since 31 Jan 03 | 532321
5%₹32 Cr667,045
↓ -89,236
Narayana Hrudayalaya Ltd (Healthcare)
Equity, Since 31 Jan 20 | NH
4%₹26 Cr580,716
↓ -34,154
Biocon Ltd (Healthcare)
Equity, Since 31 Oct 18 | 532523
4%₹24 Cr516,118
Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 532331
3%₹23 Cr137,818
↑ 8,595

5. TATA India Pharma & Healthcare Fund

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund was launched on 28 Dec 15. It is a fund with High risk and has given a CAGR/Annualized return of 8.6% since its launch.  Return for 2020 was 64.4% , 2019 was 5.5% and 2018 was -2.6% .

Below is the key information for TATA India Pharma & Healthcare Fund

TATA India Pharma & Healthcare Fund
Growth
Launch Date 28 Dec 15
NAV (19 Jan 21) ₹15.1985 ↑ 0.26   (1.71 %)
Net Assets (Cr) ₹419 on 31 Dec 20
Category Equity - Sectoral
AMC Tata Asset Management Limited
Rating Not Rated
Risk High
Expense Ratio 2.61
Sharpe Ratio 1.95
Information Ratio 0.74
Alpha Ratio 14.53
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-3 Months (0.25%),3 Months and above(NIL)

Growth of 10,000 investment over the years.

DateValue
31 Dec 15₹10,000
31 Dec 16₹8,535
31 Dec 17₹8,932
31 Dec 18₹8,697
31 Dec 19₹9,176
31 Dec 20₹15,084

TATA India Pharma & Healthcare Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹385,859.
Net Profit of ₹85,859
Invest Now

Returns for TATA India Pharma & Healthcare Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 19 Jan 21

DurationReturns
1 Month 1.9%
3 Month 12.1%
6 Month 30.5%
1 Year 58.6%
3 Year 19%
5 Year 9.4%
10 Year
15 Year
Since launch 8.6%
Historical performance (Yearly) on absolute basis
YearReturns
2020 64.4%
2019 5.5%
2018 -2.6%
2017 4.7%
2016 -14.7%
2015
2014
2013
2012
2011
Fund Manager information for TATA India Pharma & Healthcare Fund
NameSinceTenure
Rahul Singh20 Apr 200.7 Yr.
Meeta Shetty20 Apr 200.7 Yr.

Data below for TATA India Pharma & Healthcare Fund as on 31 Dec 20

Equity Sector Allocation
SectorValue
Health Care96.89%
Asset Allocation
Asset ClassValue
Cash3.11%
Equity96.89%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 18 | 500124
13%₹56 Cr107,600
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA
10%₹41 Cr690,100
Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | 500087
9%₹38 Cr460,000
Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB
8%₹36 Cr92,500
Narayana Hrudayalaya Ltd (Healthcare)
Equity, Since 29 Feb 20 | NH
7%₹29 Cr656,720
↑ 30,000
Ipca Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 16 | 524494
7%₹27 Cr125,426
Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 20 | ALKEM
6%₹26 Cr89,200
↑ 20,200
Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | 500257
5%₹20 Cr203,000
Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Jul 18 | 500126
4%₹18 Cr26,000
Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP
4%₹17 Cr70,500

6. Franklin India Technology Fund

To provide long-term capital appreciation by predominantly investing in equity and equity related securities of technology and technology related companies.

Franklin India Technology Fund is a Equity - Sectoral fund was launched on 22 Aug 98. It is a fund with High risk and has given a CAGR/Annualized return of 19.6% since its launch.  Ranked 41 in Sectoral category.  Return for 2020 was 56.8% , 2019 was 12.4% and 2018 was 11.9% .

Below is the key information for Franklin India Technology Fund

Franklin India Technology Fund
Growth
Launch Date 22 Aug 98
NAV (18 Jan 21) ₹273.988 ↓ -3.72   (-1.34 %)
Net Assets (Cr) ₹472 on 31 Dec 20
Category Equity - Sectoral
AMC Franklin Templeton Asst Mgmt(IND)Pvt Ltd
Rating
Risk High
Expense Ratio 2.46
Sharpe Ratio 1.56
Information Ratio 0.57
Alpha Ratio 7.25
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

DateValue
31 Dec 15₹10,000
31 Dec 16₹9,737
31 Dec 17₹11,595
31 Dec 18₹12,978
31 Dec 19₹14,587
31 Dec 20₹22,867

Franklin India Technology Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹493,520.
Net Profit of ₹193,520
Invest Now

Returns for Franklin India Technology Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 19 Jan 21

DurationReturns
1 Month 8.1%
3 Month 20.1%
6 Month 43.7%
1 Year 57.8%
3 Year 25.3%
5 Year 20%
10 Year
15 Year
Since launch 19.6%
Historical performance (Yearly) on absolute basis
YearReturns
2020 56.8%
2019 12.4%
2018 11.9%
2017 19.1%
2016 -2.6%
2015 3.8%
2014 16.8%
2013 53.3%
2012 0.3%
2011 -15.5%
Fund Manager information for Franklin India Technology Fund
NameSinceTenure
Anand Radhakrishnan3 Mar 0713.84 Yr.
Varun Sharma30 Nov 155.09 Yr.
Mayank Bukrediwala24 Aug 200.35 Yr.

Data below for Franklin India Technology Fund as on 31 Dec 20

Equity Sector Allocation
SectorValue
Technology67.78%
Communication Services17.28%
Consumer Cyclical4.7%
Industrials2.36%
Financial Services0.64%
Real Estate0.24%
Health Care0.11%
Asset Allocation
Asset ClassValue
Cash6.7%
Equity93.14%
Other0.16%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Infosys Ltd (Technology)
Equity, Since 29 Feb 12 | INFY
25%₹119 Cr945,647
Tata Consultancy Services Ltd (Technology)
Equity, Since 31 Aug 04 | TCS
10%₹49 Cr170,000
HCL Technologies Ltd (Technology)
Equity, Since 30 Jun 14 | HCLTECH
9%₹43 Cr450,000
Franklin Technology I Acc USD
Investment Fund | -
8%₹37 Cr91,868
Bharti Airtel Ltd (Communication Services)
Equity, Since 31 Jan 18 | BHARTIARTL
6%₹31 Cr600,000
Info Edge (India) Ltd (Communication Services)
Equity, Since 31 Jan 17 | NAUKRI
5%₹22 Cr46,300
Tech Mahindra Ltd (Technology)
Equity, Since 28 Feb 14 | 532755
5%₹21 Cr220,000
MakeMyTrip Ltd (Consumer Cyclical)
Equity, Since 31 Mar 20 | MMYT
3%₹13 Cr60,135
Taiwan Semiconductor Manufacturing Co Ltd (Technology)
Equity, Since 30 Nov 18 | 2330
3%₹12 Cr88,000
Larsen & Toubro Infotech Ltd (Technology)
Equity, Since 30 Apr 19 | 540005
2%₹11 Cr31,000

Smart Tips to Choose Best Equity Funds for 2021

A perfect way to invest in the best equity mutual funds is by looking at its both qualitative and quantitative measures.

1. Qualitative Measures

a. Know Your Fund Manager

The credit of performance of a Mutual Fund scheme lies with the fund manager. A fund manager is responsible for making investment decisions for the fund’s portfolio. So, investors should go through the performance of the funds managed by the particular fund manager, especially during the tough market phases. Also, investors should give more priority to a fund manager who has an experience of managing a similar kind of funds, for example- small and mid caps. Going for a fund manager who has been consistent over his career is a preferred choice.

b. Fund House Reputation

While choosing the best equity mutual funds to invest, always look at the quality & reputation of the fund house. A fund house with a long-standing record, large assets under management, star funds or good performing fund etc., is the one to invest in. Hence a fund house having a strong presence in the financial industry with a consistent track record should be ideally preferred.

2. Quantitative Measures

a. Fund Performance

An investor should do a fair assessment of the funds’ performances for over a period of time. Also, it is suggested to go for a fund that consistently beats its benchmark over 4-5 years, additionally, one should see each period and see if the fund is able to beat the benchmark or not.

b. Size of the Fund

Investors should always go for a fund that is neither too big nor too small in size. While there is no perfect definition and relation between the size of the fund, it is said that both too small and too large, can hinder a fund’s performance. Thus, while choosing a fund, it is advisable to go for the one whose AUM (Asset Under Management) is approximately same as the category.

3. Additional Quantitative Measures

a. Expense Ratio

Investors who have Mutual Fund Investments have to bear certain charges like operation costs, management fees, etc., charged by the Asset Management Company (AMC). Generally, the expense ratio is higher for schemes that are actively managed than it is for passively managed schemes (such as Index Funds or ETFs). As per the SEBI rules, an expense ratio for equity funds are a minimum of 2.5%.However, the expense ratio is something which should not supersede other important factors such as fund performance etc. It is better to pay a higher expense ratio in a fund knowing that it will beat it competitors by a good margin.

b. Ratio Analysis

Some of the important ratios to measure fund performance are:

c. Alpha

Alpha is a measure of the success of your investment or rather outperformance against the benchmark. It measures on how much the fund or stock has performed in the general market. A positive alpha of 1 means that the fund has outperformed its benchmark index by 1%, while a negative alpha of -1 would indicate that the fund has produced 1% lower returns than its market benchmark. So, basically, an investor’s strategy should be to buy securities with positive alpha.

d. Beta

It measures volatility in a stock’s price or fund relative to a benchmark and is denoted in positive or negative figures. A Beta of 1 signifies that the stock’s price moves in line with the market, beta of a greater than 1 designates that the stock is riskier than the market, and a beta of less than 1 means that the stock is less risky than the market. So, lower beta is better in a falling market. In a rising market, high-beta is better.

e. Standard Deviation (SD)

In simple terms, SD is a statistical measure representing the volatility or risk in an instrument. The higher the SD, higher will be the fluctuations in the returns.

f. Sharpe Ratio

Sharpe Ratio measures returns (both negative & positive) with respect to the risk taken. Here the risk is defined by the Standard Deviation. A higher Sharpe ratio means, a higher return without too much risk. Thus, while investing, investors should choose a fund that shows a higher Sharpe ratio.

g. Sortino Ratio

The Sortino Ratio is a variation of Sharpe Ratio. But, unlike Sharpe ratio, Sortino ratio considers only the downside or negative return. Such a ratio is helpful for investors to assess risk in a better manner than just looking at the returns to the total volatility.

Upside Capture Ratio & Downside Capture Ratio

Upside/downside capture ratio guide an investor- whether a fund is outperformed i.e. gained more or lost less than a broad market benchmark- during the phase of the market upside (strong) or downside (weak), and more importantly by how much.

Well, an upside ratio of over 100 means that a given fund has beaten the benchmark during the period of positive returns. And a downside ratio of less than 100 shows that a given fund has lost less than its benchmark during the phase of dull returns. So, generally, investors should go for a fund that has a lower downside capture ratio and a higher upside capture ratio.

Equity Fund Taxation

1. Long Term Capital Gains

LTCGs exceeding INR 1 lakh arising from redemption of Mutual Fund units or equities will be taxed at 10 percent (plus cess) or at 10.4 percent. Long-term Capital Gains till INR 1 lakh will be exempt.

For example, if you earn INR 3 lakhs in combined long-term capital gains from stocks or Mutual Fund investments in a financial year. The taxable LTCGs will be INR 2 lakh (INR 3 lakh - 1 lakh) and tax liability will be INR 20,000 (10 per cent of INR 2 lakh).

Long-term capital gains are the profit arising from selling or redemption of equity funds held more than a year.

2. Short Term Capital Gains

If Mutual Fund units are sold before one year of holding, Short Term Capital Gains (STCGs) tax will apply. The STCGs tax has been kept unchanged at 15 percent.

Equity Schemes Holding Period Tax Rate
Long Term Capital Gains (LTCG) More than 1 Year 10% (with no indexation)*****
Short Term Capital Gains (STCG) Less than or equal to a year 15%
Tax on Distributed Dividend - 10%#

*Gains up to INR 1 lakh are free of tax. Tax at 10% applies to gains above INR 1 lakh.
#Dividend tax of 10% + Surcharge 12% + Cess 4% =11.648% Health & Education Cess of 4% introduced. Earlier, education Cess was 3%.

How to Invest in Best Equity Mutual Funds Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.

  2. Complete your Registration and KYC Process

  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest!

    Get Started

Conclusion

While looking for best equity mutual funds, investors should choose equity funds which are doing well in the market. One should know how a fund behaves and performs when the market goes bad. A deep analysis of fund’s last three years’ performances is an ideal way to buy one of the best equity mutual funds.

Disclaimer:
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data. Please verify with scheme information document before making any investment.
How helpful was this page ?
Rated 4.5, based on 84 reviews.
POST A COMMENT